Dr. Jin-Young Choi Presented 10-Year Clinical Outcomes of V4c Implantable Collamer Lens (ICL) at the 4th EVO ICL APAC Experts Summit
At the 4th EVO ICL APAC Experts Summit held in Guangzhou, China, Dr. Jin-Young Choi from EYEREUM EYE CLINIC (Seoul, Korea) presented long-term clinical data on the safety of EVO ICL.
In this lecture, Dr. Choi presented:
“A Decade of Evidence: 10-Year Clinical Outcomes Demonstrating the Long-Term Safety of EVO ICL”
The presentation was based on clinical research conducted by the medical team at EYEREUM EYE CLINIC, published in the January 2025 issue of the American Journal of Ophthalmology:
“10-Year Clinical Outcomes of V4c Implantable Collamer Lens Implantation: Longitudinal Analysis of Visual Acuity, Endothelial Cell Density, and Vault Dynamics”
Dr. Choi shared long-term clinical findings demonstrating stable outcomes in key parameters including endothelial cell density (ECD), vault dynamics, and visual acuity, with no major complications observed throughout the 10-year follow-up period.
Highlights
• Long-term stability of endothelial cell density (ECD) and vault changes
• Sustained visual outcomes over a 10-year follow-up period
• Absence of major complications during long-term observation
• Clinical evidence supporting the long-term safety profile of EVO ICL
During the meeting, Dr. Choi also received the “Global Contribution to EVO ICL Scientific Publication” Award, recognizing his contributions to EVO ICL clinical research and scientific publications.
EYEREUM EYE CLINIC will continue striving to provide patients with trusted medical care and excellence in vision correction.
